Form 8-K - Current report:
SEC Accession No. 0001193125-24-223726
Filing Date
2024-09-23
Accepted
2024-09-23 16:34:29
Documents
15
Period of Report
2024-09-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d861822d8k.htm   iXBRL 8-K 37311
2 EX-10.1 d861822dex101.htm EX-10.1 42624
3 EX-10.2 d861822dex102.htm EX-10.2 39863
  Complete submission text file 0001193125-24-223726.txt   273641

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acad-20240917.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20240917_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20240917_pre.xml EX-101.PRE 11272
18 EXTRACTED XBRL INSTANCE DOCUMENT d861822d8k_htm.xml XML 3680
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 241316608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)